J8600 Melphalan oral 2 mg

Melphalan; oral, 2 mg

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for J8600

Physician Fee Schedule (CY 2026, RVU26D)

Status E: excluded from the PFS by regulation.

Payer policies and prior authorization for J8600

Payer coverage policies that name J8600

J8600 appears in 6 coverage policies from Aetna.

PayerPolicyRole in policyReviewedDocument
AetnaAntiemetic Therapy (0724)listed, no stanceJul 17, 2026payer document
AetnaClofarabine (0867)listed, no stanceDec 24, 2025payer document
AetnaDaratumumab (Darzalex) and Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) (0904)
Pomalidomide, lenalidomide, thalidomide, Selinexor, Venetoclax		listed, no stanceJun 8, 2026payer document
AetnaHematopoietic Colony-Stimulating Factors (CSFs) (0055)listed, no stanceJul 16, 2026payer document
AetnaHyperthermia in Cancer Therapy (0278)listed, no stanceMay 20, 2026payer document
AetnaRevakinagene Taroretcel-lwey (Encelto) (1079)listed, no stance (range J8501-J9999)Oct 5, 2026payer document

Medicaid fee-for-service

  • AZ: $9.16 (outpatient_hospital), effective Oct 1, 2024
  • IN: $8.18 (professional, Advanced Practice Nurse (85%), non-facility), effective Oct 1, 2017
  • KY: $0.00 (asc), effective Jan 1, 2026
  • NE: $9.78 (injectables), effective Jul 1, 2026
  • OH: $12.00 (provider_administered_drugs), effective Nov 1, 2018
  • VA: $12.00 (medical), effective Oct 1, 2018
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WA: $9.16 (professional_administered_drugs), effective Jul 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.